Atlas Trials

Dose-Finding of Propranolol in Combination With Metronomic Fixed Oral Cyclophosphamide Based on Bivariate Efficacy-tolerability Outcome in Patients With Locally Advanced or Metastatic Angiosarcoma: A Collaborative and Innovative Phase I-II Sequential Trial by the French Sarcoma Group (GSF/GETO)

Clinical trial NCT02732678 · UNKNOWN

Trial details

NCT number
NCT02732678
Sponsor
Assistance Publique Hopitaux De Marseille
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Angiosarcoma
Start date
2016-05-01
Primary completion
2018-05-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.